Another study identified BNC1 and ADAMTS1 hypermethylation as potential biomarker to detect early‐stage pancreatic cancer, with sensitivities of 79% and 48% and specificities of 89% and 92%, respectively. This evidence concerns the gene BNC1 and pancreatic neoplasm.